All AEs and SAEs should be followed up until they have resolved or stabilized or until 30 days after the participant’s involvement in the study has ended, whichever comes first.
Data and safety monitoring must occur periodically throughout every study to protect participant safety and ensure the integrity of study data. NIDA has established Data and Safety Monitoring Boards to monitor the conduct of all CTN clinical trials.